Related Experiment Video

Updated: Aug 15, 2026

Author Spotlight: Advancements in In Vivo and Ex Vivo Retinal Imaging for Improved Glaucoma Diagnosis and Treatment
07:02

Author Spotlight: Advancements in In Vivo and Ex Vivo Retinal Imaging for Improved Glaucoma Diagnosis and Treatment

Published on: June 30, 2023

1.4K

Innovations in diabetic retinopathy screening in the UK

Sobha Sivaprasad1

  • 1NIHR Moorfields Biomedical Research Centre, Medical Retina, Moorfields Eye Hospital, London, EC1V 2PD, UK.

The Lancet. Diabetes & Endocrinology
|January 16, 2025
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Author Spotlight: Understanding Retinal Vessel Resilience and Disease Progression
04:36

Author Spotlight: Understanding Retinal Vessel Resilience and Disease Progression

Published on: January 12, 2024

1.0K
Subjective Refraction Test Using a Smartphone for Vision Screening
05:36

Subjective Refraction Test Using a Smartphone for Vision Screening

Published on: October 18, 2024

594

Related Experiment Videos

Last Updated: Aug 15, 2026

Author Spotlight: Advancements in In Vivo and Ex Vivo Retinal Imaging for Improved Glaucoma Diagnosis and Treatment
07:02

Author Spotlight: Advancements in In Vivo and Ex Vivo Retinal Imaging for Improved Glaucoma Diagnosis and Treatment

Published on: June 30, 2023

1.4K
Author Spotlight: Understanding Retinal Vessel Resilience and Disease Progression
04:36

Author Spotlight: Understanding Retinal Vessel Resilience and Disease Progression

Published on: January 12, 2024

1.0K
Subjective Refraction Test Using a Smartphone for Vision Screening
05:36

Subjective Refraction Test Using a Smartphone for Vision Screening

Published on: October 18, 2024

594

Related Concept Videos

Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...

Articles linked to this work by shared authors, journal, and citation graph.

A Randomized-Controlled Trial of the Efficacy, Safety and Tolerability of Intravitreal Brolucizumab in Patients With Chronic Central Serous Chorioretinopathy With Persistent Fluid in the Absence of Choroidal Neovascular Membrane-BRICS Trial Report II.

American journal of ophthalmology·2025

Trends in Mortality from Diabetes and Other Non-Communicable Diseases Among Sri Lankan Adults: A Retrospective Population-Based Study, 2004-2020/2021.

Journal of clinical medicine·2025

Prevalence of Type 2 Diabetes Mellitus and Its Microvascular Complications in Sri Lanka: A Systematic Review and Meta-Analysis.

Cureus·2025

Validation of Macular Telangiectasia Type-2 (MacTel) multimodal imaging-based classification system in a cohort from India.

Eye (London, England)·2025

Microvascular changes in the macular area in patients with obstructive sleep apnoea syndrome compared to controls: A systematic review and meta-analysis.

Eye (London, England)·2025

Real-World Prospective Validation and Economic Evaluation of Deep Learning- Based Diabetic Retinopathy Detection From Fundus Photographs: A Systematic Review and Meta-analysis.

Diabetes care·2025

From adiposity to multisystem morbidity: the case for weight loss as disease modification.

The lancet. Diabetes & endocrinology·2026

Efficacy and safety of mazdutide in adults with obesity or overweight: a US-based, multicentre, phase 2, randomised, placebo-controlled clinical trial.

The lancet. Diabetes & endocrinology·2026

Long-term safety of oral orforglipron in Japanese participants with type 2 diabetes (ACHIEVE-J): a multicentre, randomised, open-label, parallel-group phase 3 trial.

The lancet. Diabetes & endocrinology·2026

Once-weekly IcoSema versus once-daily insulin glargine U100 in type 2 diabetes management (COMBINE 4): an open-label, multicentre, treat-to-target, randomised, phase 3b trial.

The lancet. Diabetes & endocrinology·2026

Efficacy and safety of once-weekly semaglutide 2·4 mg in Chinese adults with overweight or obesity (STEP 12): a randomised, double-blind, placebo-controlled, multicentre, phase 3b trial.

The lancet. Diabetes & endocrinology·2026

Effect of semaglutide on kidney outcomes in the SELECT, FLOW, and SOUL trials: a prespecified pooled analysis.

The lancet. Diabetes & endocrinology·2026

A balanced multimodal decoding framework of EEG and fNIRS for motor imagery.

Cognitive neurodynamics·2026

A self-triggering and fully sustainable gastric device enabling long-acting oral delivery of macromolecules.

Science advances·2026

Multimodal biosensors: a review of signal synergy mechanisms, construction strategies, and application prospects.

Analytical methods : advancing methods and applications·2026

Real-World Glycemic Outcomes of Open-Source Automated Insulin Delivery During 12 Months Among People With Type 1 Diabetes Across Age Groups.

Diabetes, obesity & metabolism·2026

Neural processing of natural speech by adults with and without dyslexia: Evidence for atypical temporal sampling of speech information in the delta and theta EEG bands.

Cortex; a journal devoted to the study of the nervous system and behavior·2026

From Sensing Mechanisms to System Co-Design: Graphene-Based Sensors and Readout Circuits.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us